PHENYTOIN SODIUM DIN 02460912
Health Canada record
| Active ingredient(s) | PHENYTOIN SODIUM 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AB02 PHENYTOIN |
| Original market date | 16-Aug-2017 |
| Current status date | 13-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
AA Pharma Inc. — licence 101851, currently licensed, last inspection rating C (2023-05-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PHENYTOIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00022780 | DILANTIN | BGP PHARMA ULC | Capsule | PHENYTOIN SODIUM 100 MG | Marketed |
| 00022772 | DILANTIN | BGP PHARMA ULC | Capsule | PHENYTOIN SODIUM 30 MG | Marketed |
| 00780626 | PHENYTOIN SODIUM INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | PHENYTOIN SODIUM 50 MG | Marketed |
| 02431378 | PHENYTOIN SODIUM INJECTION USP | HIKMA CANADA LIMITED | Solution | PHENYTOIN SODIUM 50 MG | Marketed |
| 00245453 | DILANTIN INJ 50MG/ML | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Liquid | PHENYTOIN SODIUM 250 MG | Cancelled Post Market |
| 00275131 | DILANTIN W PHENOBARBITAL 15MG | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Capsule | PHENYTOIN SODIUM 100 MG; PHENOBARBITAL 15 MG | Cancelled Post Market |
| 00439770 | DILANTIN W PHENOBARBITAL 30MG CAP | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Capsule | PHENYTOIN SODIUM 100 MG; PHENOBARBITAL 30 MG | Cancelled Post Market |
| 00037435 | NOVO-PHENYTOIN CAP 100MG | NOVOPHARM LIMITED | Capsule | PHENYTOIN SODIUM 100 MG | Cancelled Post Market |
| 00498335 | PHENYTOIN SODIUM INJECTION USP | JUNO PHARMA CANADA INC. | Solution | PHENYTOIN SODIUM 50 MG | Dormant |
| 00497304 | PHENYTOIN SOIDUM INJECTION USP | PFIZER CANADA ULC | Solution | PHENYTOIN SODIUM 50 MG | Cancelled Post Market |
| 02468255 | TARO-PHENYTOIN | TARO PHARMACEUTICALS INC | Capsule | PHENYTOIN SODIUM 100 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25307 | 2021-02-26 | Abbreviated New Drug Submission (ANDS) | CHANGE IN PRODUCT OWNERSHIP |
| 18906 | 2017-01-26 | Abbreviated New Drug Submission (ANDS) |
International API supply for PHENYTOIN SODIUM
1 valid EDQM Certificates of Suitability from 1 holders. 12 active FDA Drug Master Files.
Request a quote for PHENYTOIN SODIUM